What Happened
A recent study has identified 15 Indian stocks, each with a market capitalization exceeding Rs 1,500 crore, that have consistently generated over 20% returns during the July-September quarter for the last three consecutive years. This highlights a strong seasonal trend and potential momentum for these specific scrips as the new quarter approaches.
Why It Matters (for you)
This analysis is significant for Indian traders as it points to a recurring pattern of outperformance, suggesting that these stocks might continue their upward trajectory in the upcoming quarter. Such seasonal strength, especially when coupled with strong annual returns, can be a powerful indicator for short-to-medium term trading strategies, offering potential entry points.
Impact on Indian Markets
While specific stock names are not provided in the article, the general implication is positive for the identified 15 companies. Traders should look for stocks that have shown consistent Q3 gains and strong annual performance. This trend could attract increased buying interest in these specific stocks, potentially leading to price appreciation.
What Traders Should Watch Next
Traders should actively seek out the names of these 15 identified stocks and conduct further fundamental and technical analysis. Monitor their performance as the July-September quarter begins, looking for confirmation of the seasonal trend. Pay attention to any news or events specific to these companies that could either reinforce or negate this historical pattern.
Key Evidence
- 15 stocks with market capitalisation above Rs 1,500 crore delivered over 20% returns in each of the last three July-September quarters.
- Most of these stocks also posted strong one-year returns.
- The trend suggests momentum combined with seasonal strength for continued outperformance potential.
- Risk flag: Regulatory changes or adverse USFDA observations could impact pharma stocks.
- Risk flag: Increased competition or pricing pressure on key drugs.